Company: ARAI
Filing Date: 2025-01-27
Form Type: S-1/A
Source: 0001493152-25-003660
Chunk: 68

Company: Arrive AI Inc.
Filing Date: 2025-01-27
Form: S-1/A
Chunk 68
---
 milestones for achieving revenue for sustainable operations include:

○ Initial AP3 deployments beginning November 2024, expanding through 2025

○ Implementation of contracted use cases in Specialty Pharma and Assisted Living communities in 2025, with potential expansion to hospital environments; no agreements exist as of the date of this prospectus

○ Completion of
AP4 development with a Fortune 500 logistics customer, featuring reverse logistics and pickup capabilities, for 2025 deployment

○ Development
of AP5, our comprehensive “universal” solution supporting all drone and robotic delivery operations, with development starting
2025, pilots in 2026, and general availability in 2027

Our path to profitability relies on achieving product-market fit, for the growing number of ALM automation operators and the businesses seeking to use ALM automation for delivery savings and improved customer experience. We will be able to meet their needs after the successful development and deployment of AP3, AP4, and AP5 (our 3rd, 4th, and 5th generation of ALM Access Points), which will provide universal support for all autonomous delivery systems. AP3 is complete and being installed for customers in November 2024, and AP4 is presently in development with a F500 customer and is on-track to be deployed in 2025. Success requires delivering a user-friendly, competitively priced solution with scalable manufacturing, marketing, and distribution meeting the needs for a universal ALM Access Point for all drone, robotic, and human pickup and delivery. Once achieved as scheduled in 2026 with AP5, we can pursue broader market adoption beyond pilot programs to generate scalable and sustainable revenue growth. While we believe in our plans, and are optimistic that we can continue to achieve them, there is no guarantees that we will achieve product market fit or be successful in our commercialization and plans.

| 28 |

Factors Affecting our Business and Results of Operations

This section includes a summary of our historical results of operations, followed by detailed comparisons of our results for the nine months ended September 30, 2024 and the nine months ended September 30, 2023. We have derived this data from our financial statements included elsewhere in this prospectus.

The Company’s auditor has completed a review of its 2024 and 2023 financial performance in accordance with the standards of the PCAOB. The Company has not started commercial operations but has incurred expenses in connection with corporate and administrative matters, upkeep of acquired properties for future growing, processing and